Trade ADIL stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Adial Pharmaceuticals, Inc (ADIL) is trading at US$3.90, down 1.76% today as of Oct 9, 16:00 EDT. The company has a market capitalisation of US$16.32M. Over the past 52 weeks, ADIL has traded between US$1.31 and US$10.19. On Syfe you can trade ADIL with $0 commission and add it to your watchlist.
| Previous close | US$3.97 |
|---|---|
| Market cap | US$16.32M |
| 52-week range | US$1.31 – US$10.19 |
| Volume | 3.04K |
| Exchange | US |
Adial Pharmaceuticals, Inc
Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.
Year: 2018
Adial Pharmaceuticals Closes First $32 Million Tranche of Financing
Jun 16, 12:44 PM · MT Newswires
Sector Update: Healthcare Stocks Higher Late Afternoon
Jun 11, 7:28 PM · MT Newswires
Sector Update: Healthcare
Jun 11, 7:04 PM · MT Newswires
Top Midday Gainers
Jun 11, 5:37 PM · MT Newswires
Adial Pharmaceuticals Acquires Azora Therapeutics
Jun 11, 4:14 PM · MT Newswires
Adial Pharmaceuticals, Inc (ADIL) stock is trading at US$3.90, -1.76% from the previous close of US$3.97.
The market cap for Adial Pharmaceuticals, Inc (ADIL) stock is approximately US$16.32M.
The 52-week high for Adial Pharmaceuticals, Inc (ADIL) stock is US$10.19.
The 52-week low for Adial Pharmaceuticals, Inc (ADIL) stock is US$1.31.
Adial Pharmaceuticals, Inc (ADIL) does not currently pay a dividend.
Stay on top of ADIL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
